Delivery Order SPE2DE24DA010-SPE2D625F0RGY
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $49.8K by the Department of Defense's Medical Supply Chain for the delivery of Aveir Leadless Pacemakers. The contract, awarded on August 1, 2025, with an ultimate completion date of August 6, 2025, will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition. The award represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,500 delivery order on July 28, 2025, for leadless accessories to support federal healthcare operations. The contract, which carries no set-aside designation and operates under fixed-price pricing with economic price adjustment terms, is funded by the Medical Supply Chain division of the Department of Defense and will be performed in Santa Clara, California. This delivery order represents a continuation of...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, for the delivery of Aveir Leadless Dual Chamber Pacemakers. The $48,700.00 firm fixed price delivery order contract has a completion date of May 5, 2025. Abbott Laboratories Inc. is a large pharmaceutical and medical device manufacturer that has been awarded multiple federal contracts and indefinite delivery/indefinite quantity (IDIQ) vehicles to...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,495 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of August 4, 2025. This delivery order, which contains no set-aside designation indicating full and open competition, represents a call against a larger indefinite delivery contract vehicle. The work will be performed in Santa Clara, California, and involves the...
- This federal contract award was issued by the Medical Supply Chain division of the Defense agency to Abbott Laboratories Inc., a large medical device manufacturer. The $10,568.00 fixed-price delivery order is for the delivery of low voltage pacers and related cardiovascular medical devices. The contract has no set-aside designation, indicating full and open competition. Abbott Laboratories Inc. has been awarded numerous federal contracts by the Department of Veterans Affairs (VA) and Defense...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $28,350.00 fixed-price with economic price adjustment delivery order is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The award has an ultimate completion date of November 27, 2024....
- This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
- This federal contract award was issued by the Medical Supply Chain, a Defense agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $25,715.85 fixed-price delivery order contract, awarded on July 9, 2025, has an ultimate completion date of July 14, 2025 and does not utilize a set-aside designation. The contract requires Abbott Laboratories to provide a range of cardiovascular medical devices and technologies, including stents, pacemakers, heart valves, implantable...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F0RGYDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place of performance in Santa Clara, California, reflecting Abbott's established role as a critical supplier of advanced cardiovascular medical technologies to federal defense healthcare systems. This delivery order represents a continuation of Abbott's extensive federal contracting relationship with the Defense Logistics Agency, which has previously awarded the company a substantial $117.1 million indefinite delivery contract for comprehensive cardiovascular procedural packages. The AVEIR Leadless Pacemaker is a sophisticated implantable cardiac device that supports complex medical procedures within federal healthcare systems. As a child entity of the parent Abbott Laboratories Inc., Abbott Vascular Inc. brings decades of expertise in developing and manufacturing specialized cardiovascular devices, positioning it as a preferred vendor for federal procurement of advanced medical technologies supporting defense and veterans' healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 8/11/25 |